Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cancer stem cell marker CD90 inhibits ovarian cancer formation via β3 integrin

15 Sept 2016

Abstract excerpt

Cancer stem cell (CSC) markers have been identified for CSC isolation and proposed as therapeutic targets in various types of cancers. CD90, one of the characterized markers in liver and gastric cancer, is shown to promote cancer formation. However, the underexpression level of CD90 in ovarian cancer cells and the evidence supporting the cellular mechanism have not been investigated. In the present study, we...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to RNA modifications and cancer
Share to Cancer Cells and Metastasis
Share to Cancer Genomics and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27633757
DOI: 10.3892/ijo.2016.3691

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cancer stem cell marker CD90 inhibits ovarian cancer formation via β3 integrinPMID 27633757Read ↗

Identification of CD90 as a marker for lung cancer stem cells in A549 and H446 cell linesSemantic proximity Read ↗

A comprehensive overview of ovarian cancer stem cells: correlation with high recurrence rate, underlying mechanisms, and therapeutic opportunitiesSemantic proximity Read ↗

miR-548c-5p inhibits proliferation and migration and promotes apoptosis in CD90+ HepG2 cellsSemantic proximity Read ↗

Significance of CD90+ Cancer Stem Cells in Human Liver CancerSemantic proximity Read ↗

Characterization of stem cell and cancer stem cell populations in ovary and ovarian tumorsSemantic proximity Read ↗

Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype.Semantic proximity Read ↗

Gene Expression Profiling of Liver Cancer Stem Cells by RNA-SequencingSemantic proximity Read ↗

Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cellsSemantic proximity Read ↗

Surface markers of cancer stem-like cells of ovarian cancer and their clinical relevanceSemantic proximity Read ↗

Ovarian cancer stem cell: A potential therapeutic target for overcoming multidrug resistanceSemantic proximity Read ↗

Epithelial ovarian cancer stem cells: underlying complexity of a simple paradigmSemantic proximity Read ↗

Ovarian cancer cells with the CD117 phenotype are highly tumorigenic and are related to chemotherapy outcome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.